# Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

> **NCT02412241** · NA · COMPLETED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 118 (actual)

## Conditions studied

- Oral Cavity Cancer
- Oropharyngeal Cancer
- Lymphedema
- Fibrosis

## Interventions

- **OTHER:** LEF measures
- **PROCEDURE:** Technical measure
- **PROCEDURE:** Technical measure

## Key facts

- **NCT ID:** NCT02412241
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2021-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412241, "Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02412241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*